Literature DB >> 20887560

Two different unique cardiac isoforms of protein 4.1R in zebrafish, Danio rerio, and insights into their cardiac functions as related to their unique structures.

Kenji Murata1, Wataru Nunomura, Yuichi Takakuwa, Gary N Cherr.   

Abstract

Protein 4.1R (4.1R) has been identified as the major component of the human erythrocyte membrane skeleton. The members of the protein 4.1 gene family are expressed in a tissue-specific alternative splicing manner that increases their functions in each tissue; however, the exact roles of cardiac 4.1R in the developing myocardium are poorly understood. In zebrafish (ZF), we identified two heart-specific 4.1R isoforms, ZF4.1RH2 and ZF4.1RH3, encoding N-terminal 30 kDa (FERM) domain and spectrin-actin binding domain (SABD) and C-terminal domain (CTD), separately. Applying immunohistochemistry using specific antibodies for 30 kDa domain and CTD separately, the gene product of ZF4.1RH2 and ZF4.1RH3 appeared only in the ventricle and in the atrium, respectively, in mature hearts. During embryogenesis, both gene expressions are expressed starting 24 h post-fertilization (hpf). Following whole-mount in situ hybridization, ZF4.1RH3 gene expression was detected in the atrium of 37 hpf embryos. These results indicate that the gene product of ZF4.1RH3 is essential for normal morphological shape of the developing heart and to support the repetitive cycles of its muscle contraction and relaxation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887560     DOI: 10.1111/j.1440-169X.2010.01195.x

Source DB:  PubMed          Journal:  Dev Growth Differ        ISSN: 0012-1592            Impact factor:   2.053


  3 in total

1.  Insights into the Function of the Unstructured N-Terminal Domain of Proteins 4.1R and 4.1G in Erythropoiesis.

Authors:  Wataru Nunomura; Philippe Gascard; Yuichi Takakuwa
Journal:  Int J Cell Biol       Date:  2011-08-28

2.  Increased expression of FERM domain-containing 4A protein is closely associated with the development of rectal cancer.

Authors:  Yongtian Fan; Dechuan Li; Jun Qian; Yong Liu; Haiyang Feng; Dechuan Li
Journal:  Exp Ther Med       Date:  2015-12-11       Impact factor: 2.447

3.  FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma.

Authors:  Xianghuai Zheng; Bo Jia; Xi Lin; Jiusong Han; Xiaoling Qiu; Hongxing Chu; Xiang Sun; Weitao Hu; Jie Pan; Jun Chen; Jianjiang Zhao
Journal:  Int J Mol Med       Date:  2016-09-21       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.